# How does LL-37 influence neuroinflammation in aging and neurodegeneration?

Canonical source: https://retacompare.com/research/how-does-ll-37-influence-neuroinflammation-in-aging-and-neurodegeneration

Peptide Longevity Q&A · 2026-01-01


    Research indicates that LL-37, an antimicrobial peptide, plays a significant role in neuroinflammation associated with neurodegenerative diseases. It is released from neurons and activates glial cells, leading to increased inflammatory cytokine production and decreased neuronal survival, linking immunity to neurobiology.

 What the research shows

The study reviewed various roles of antimicrobial peptides (AMPs), particularly LL-37, in neurodegeneration using Drosophila models of diseases such as Huntington's disease, Alzheimer's disease, and Parkinson's disease. It focused on the dysregulation of AMPs in glial and neuronal tissues, emphasizing their involvement in neuroinflammation and mitochondrial dysfunction. The research highlighted that LL-37 is released from neurons and activates glial cells, which subsequently boosts the production of inflammatory cytokines, ultimately leading to neuronal loss. The findings suggest that the immune pathways, such as the Toll and immune deficiency pathways, drive the expression of LL-37 in a manner reminiscent of inflammatory processes observed in human neurodegenerative diseases.

 Why it matters for longevity

Understanding the role of LL-37 in neuroinflammation is crucial for longevity research as chronic inflammation is a significant contributor to age-related neurodegenerative diseases. The dysregulation of LL-37 may exacerbate neuroinflammatory responses, leading to accelerated neuronal loss and cognitive decline. By elucidating the dual role of LL-37 in both immune defense and neurobiology, researchers can better understand how to maintain brain homeostasis and potentially mitigate the effects of aging on cognitive function. This research underscores the importance of AMPs in not only fighting infections but also in maintaining neurological health as individuals age.

 Key findings at a glance

LL-37 is an antimicrobial peptide involved in innate immunity.

It is implicated in neuroinflammation and neurodegeneration.

Increased levels of LL-37 are observed in the cerebrospinal fluid of patients with meningitis.

LL-37 activates glial cells, enhancing inflammatory cytokine production.

The dysregulation of LL-37 is linked to neuronal loss in neurodegenerative diseases.

Research models indicate that immune pathways drive persistent expression of LL-37.

 How LL-37 works (background)

LL-37 is a member of the cathelicidin family of antimicrobial peptides, crucial for innate immunity. It functions by disrupting microbial membranes and modulating immune responses. In the context of neurodegeneration, LL-37's role extends beyond antimicrobial activity; it influences glial cell activation and cytokine production, which are critical in the inflammatory processes associated with neurodegenerative conditions. The interplay between LL-37 and neuroinflammation suggests a complex relationship where it can act as both a protective agent and a promoter of inflammation, impacting neuronal health.

 Safety, caveats, and what we don't yet know

While the findings regarding LL-37 provide valuable insights, there are limitations to the current research. Most studies have been conducted in preclinical models, primarily using Drosophila, which may not fully replicate human neurobiology. Additionally, the long-term effects of altered LL-37 levels in humans and their implications for aging and neurodegeneration require further investigation. More research is needed to explore the therapeutic potential of modulating LL-37 levels in various populations, particularly in older adults or those with neurodegenerative diseases.

 Bottom line

LL-37 plays a significant role in neuroinflammation and neurodegeneration, linking immune responses to neuronal health. Its dysregulation may contribute to cognitive decline, emphasizing the need for further research in the context of aging.

 Related questions

 Can LL-37 protect against neurodegenerative diseases?

Research suggests that while LL-37 can have protective roles, its dysregulation may lead to increased neuroinflammation, potentially exacerbating neurodegenerative diseases.

 What is the role of antimicrobial peptides in aging?

Antimicrobial peptides like LL-37 are involved in immune responses and may influence inflammatory processes, which are critical in the aging brain and neurodegeneration.

 How does neuroinflammation affect cognitive function in older adults?

Neuroinflammation is linked to cognitive decline in older adults, as chronic inflammation can lead to neuronal damage and exacerbate neurodegenerative conditions.

 Source: PubMed · Adv Protein Chem Struct Biol · published 2026-01-01.

## Sources

- PubMed · Adv Protein Chem Struct Biol: https://pubmed.ncbi.nlm.nih.gov/41581940/